During the week of February 23 – March 1, 2014, fellows from the University of South Florida guided by their chief Rafael Carrion MD, captured video of complicated Peyronie’s cases treated with Dr. Perito’s novel “Scratch” technique. These video files will be submitted to Video Textbook Library and the national meeting for the Society of Sexual Medicine.
During this training program producers from Vice.com were shadowing the training process filming content for a piece focusing on the “nuts and bolts” of the penile implant – March 3, 2014
Video Presentations on both Infrapubic Penile Implantation and The “Scratch” Technique are scheduled to be presented at the Italian Andrological Society Meeting on May 28, 2014. This is a turning point for Italy who was formerly doing almost no Infrapubic Penile Implants directly reflecting international growth for Dr. Perito and Perito Urology’s Training Program on Minimally Invasive Infrapubic Penile Implantation
Urologicke’ is a popular periodical of the Czech and Slovak urologists. They have a high level of quality in these published review articles by leading Czech and foreign experts in the field of urology, supplemented by comprehensive particulars and attached images. Urologicke’ is gaining popularity among readers thanks to its practical application of current guidelines for urology including guidelines from the European Association of Urology.
Dr. Perito has coauthored the largest series of its kind in regards to Penile Implantation. This was published in the Journal of Sexual Medicine Volume 11, #2 “Outcomes of Abdominal Wall Reservoir Placement in Inflatable Penile Prosthesis Implantation: A Safe and Efficacious Alternative to the Space of Retzius”. Together the authors have described the safest way to place a Penile Implant reservoir precluding any chance for a major bowel bladder or vascular injury. -February 2014
Global Stem Cells, Inc., Bioheart, Inc., and Paul Perito Urology Announce Plans to Launch Stem Cell Clinical Trials for Treatment of Erectile Dysfunction (ED)
Global Stem Cells Group and Bioheart, Inc. have announced the launch of a clinical trial for the treatment of erectile dysfunction (ED) using adipose-derived stem cell technology.
Miami, FL (PRWEB) February 11, 2014
Global Stem Cells Group,Bioheart, Inc., and Paul Perito Urology announce plans to launch stem cell clinical trials for treatment of Erectile Dysfunction (ED).
Paul Perito, M.D. of Perito Urology in Coral Gables, Florida and the principal investigator of the trial study, titled, “An Open-label, Non-randomized, Single-center Study to Assess the Safety and Effects of Autologous Adipose-derived Stromal Cells Delivered into the Corpus Cavernosum in Patients with Erectile Dysfunction,” aims to assess the safety and efficacy of stem cell implantation therapy in patients with ED.
The cell therapy in this study will be composed of stem cells derived from a patient’s own adipose (fat) tissue, harvested by syringe liposuction. The adipose stem cells will then be delivered into the corpus cavernosum of the penis.
Clinical trials will be held at Perito Urology, in cooperation with Global Stem Cells Group and Bioheart. Up to 20 patients will be enrolled.
Fort Myers Florida-based Emcyte Corporation, a leading provider of biotechnology products for platelet rich plasma and bone marrow concentrate grafting procedures, will be providing systems and kits to be used in the trial.
To learn more about Global Stem Cells Group’s clinical trials, and for investor information, visit the Global Stem Cell Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.
About the Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
About Bioheart, Inc.:
Bioheart committed to maintaining its leading position within the cardiovascular sector of the cell technology industry delivering cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues.
Bioheart’s goals are to cause damaged tissue to be regenerated, when possible, and to improve a patient’s quality of life and reduce health care costs and hospitalizations.
Specific to biotechnology, Bioheart is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. Its leading product, MyoCell, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient’s heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients. For more information on Bioheart, visit http://www.bioheartinc.com, or visit us on Facebook: Bioheart and Twitter @BioheartInc.
About Paul Perito, M.D.:
Paul Perito, M.D. is a top urological surgeon who excels in men’s sexual health and the treatment of erectile dysfunction (ED). Perito Urology is among the world’s top penile implant facilities. Completing more than 500 successful penile implant surgeries each year, Perito Urology offers a spectrum of services that include the treatment of Peyronie’s Disease and all other forms of urologic care related to erectile function and men’s health. The clinic is located near Miami, Florida in Coral Gables.
Perito is Chairman of Urology at Coral Gables Hospital and an active, Board Certified member of the American Urological Association. He is a Fellow of the American College of Surgeons, member of the Sexual Medicine Society and a member of the Society of Prosthetic Surgeons. Perito has established a penile implant training program for surgeons wishing to learn his minimally invasive technique. For more information on Perito and Perito Urology, visit his website PeritoUrology.com.
On Saturday Morning January 18, 2014 Dr. Perito presented his Minimally Invasive Technique on Penile Implantation in front of an audience of Doctors and Cosmetic Surgeons from around the World. During this meeting Doctors discussed new advancements in treatments involving Men’s Sexual Health and Erectile Dysfunction as well as cosmetic procedures for the penis. He also visited Doral Surgical Center’s booth where he presented new treatments that can restore sexual function. Dr. Perito performs this and other ambulatory surgical procedures at locations including The Surgery Center at Doral, an International Sports Medicine & Surgical Center in Miami, Florida. Check out the Procedures section of our web-site to learn more on these procedures.
Dr. Perito traveled to Rome over Thanksgiving to train a group of Italian Doctors on his Minimally Invasive Penile Implant Technique. This training event with SAPIENZA – The University of Rome, allowed a group of Italian Doctors to experience hands-on techniques designed by Dr. Perito to perfect his Minimally Invasive Infrapubic Penile Implant Technique. This event combined Live Surgery with Live Questions and Answers broadcast to an auditorium filled with Andrologists. During this trip Dr. Perito also proctored a panel to discuss advancements in Penile Implantation.
About The Sexual Medicine Society of North America
The Sexual Medicine Society of North America provides a forum for the free exchange and discussion of new ideas, thoughts, and concepts in sexual medicine. Consisting of over 700 active members, the organization is composed of North American surgeons, physicians, mental health professionals, scientists, residents and medical students, all committed to sexual health.
Dr. Perito’s involvement in this meeting included:
1. Clinical Abstracts
072 IMPROVED INFECTION OUTCOMES AFTER MULCAHY SALVAGE PROCEDURE AND REPLACEMENT OF INFECTED IPP WITH MALLEABLE PROSTHESIS
Martin Gross, MD1; Daniel Martinez, MD2; Rafael Carrion, MD2; Paul Perito, MD3; Laurence Levine, MD4; Jason Greenfield, MD5; Ricardo Munarriz, MD1
1: Boston University Medical Center, Boston, MA; 2: University of South Florida, Tampa, FL; 3: Perito Urology, Coral Gables, FL; 4: Rush University Medical Center, Chicago, IL; 5: Urology Associates of North Texas, Arlington, TX
073 EFFECT OF OPERATIVE LOCAL ANESTHESIA ON POSTOPERATIVE PAIN OUTCOMES OF INFLATABLE PENILE PROSTHESIS : PROSPECTIVE COMPARISON OF TWO MEDICATIONS
Marilin Nicholson, MD1; Fernando Bianco, MD2; Paul Perito, MD2; Angel Perez, ARNP2; Igor Kislinger, MD2; Edward Gheiler, MD, FACS2
1: Urological Research Network; 2:Urological Research Network, Hialeah, FL
138 OUTCOMES OF ABDOMINAL WALL RESERVOIR PLACEMENT IN INFLATABLE PENILE PROSTHESIS IMPLANTATION: A SAFE AND EFFICACIOUS ALTERNATIVE TO THE SPACE OF RETZIUS
Doron S. Stember, MD1; Bruce B, Garber, MD2; Paul E. Perito, MD3
1: Beth Israel Medical Center of Albert Einstein College of Medicine, New York, NY; 2: Hahnemann University Hospital, Philadelphia, PA; 3: Perito Urology, CoralGables, FL
153 TRENDS IN SURGICAL APPROACH OF PENILE PROTHESIS SURGERY OVER THE PAST 13 YEARS
Doron S. Stember, MD1; Paul E. Perito, MD2; Peter J. Stahl3
1: Beth Israel Medical Center of Albert Einstein College of Medicine, New York, NY; 2: Perito Urology, Coral Gables, FL; 3: Columbia University College of Physicians and Surgeons, New York, NY
2. Panel Discussion
Changing the Paradigms in the Treatment of ED. Andrew C. Kramer, MD; John J. Mulcahy, MD; Steven K Wilson, MD; Gerard D Henry, MD; Paul E Perito, MD; Culley C Carson, MD; Lawrence A Levine, MD; and Francois Eid, MD
3. Dr. Perito proctors for the cadaveric surgical skills workshop at the Sexual Medicine Society Meeting in New Orleans on Sunday, November 24, 2013.
Dr. Perito explains the Titan Penile Implant, its function, and the reality that a Penile Implant is sometime the only alternative for some men suffering with Erectile Dysfunction. Click here to watch…
New procedure administered under local anesthesia will help men with BPH symptom relief and improved urinary flow with preserved sexual function
Perito Urology now offers a new procedure proven to significantly improve the quality of life for those suffering Benign Prostatic Hyperplasia (BPH) better known as enlarged prostate. Cleared by the U.S. Food and Drug Administration in September 2013, clinical research has shown that patients receiving the UroLift® System implants reported rapid improvement in their symptoms including increased urinary flow rates and preserved sexual function.
The UroLift System provides an alternative to tissue removing surgery for the treatment of an enlarged prostate. Small permanent implants, delivered during a minimally-invasive procedure, act like window curtain tie-backs to hold the lobes of an enlarged prostate open. Patients recover from the procedure quickly, and return to their normal routines with minimal downtime.
BPH is a common condition affecting more than 500 million men worldwide. Symptoms include loss of productivity, sleep, depression and decreased quality of life. Medication has long been the first line for treatment but in some instances this has proven inadequate and only temporary. Some patients suffer sexual dysfunction, dizziness and headaches leading them to cease taking their medication.
Dr. Paul Perito, renowned thought leader in Men’s Sexual Health said, “Perito Urology is looking forward to changing the lives of many men through the UroLift® procedure which is proven to improve urinary flow rates and preserve sexual function.”
“We are very pleased that Perito Urology is now offering patients the UroLift® System which can make a significant difference in the lives of aging men.” stated Dave Amerson, President & CEO of NeoTract Inc. “Men suffering from BPH should know that they do not need to suffer in silence and can get rapid relief for their condition.”
